473 results on '"Brouard Sophie"'
Search Results
2. Blood MMP-9 measured at 2 years after lung transplantation as a prognostic biomarker of chronic lung allograft dysfunction
Catalog
Books, media, physical & digital resources
3. Inhibition of cystathionine-γ-lyase controls interleukin-12 production by dendritic cells, delayed-type hypersensitivity and transplant rejection
4. No lack of regulatory B cells in patients with Multiple Sclerosis
5. Deficiency of regulatory B cells in a house dust mite model of asthma
6. Characterization of murine experimental autoimmune encephalomyelitis induced by active immunization with a CD8 epitope of myelin oligodendrocyte glycoprotein
7. A phenotypic, transcriptional and TCR Vβ repertoire signature of CD8+ T cells define a population at-risk of long-term kidney graft dysfunction
8. The blood of healthy individuals exhibits CD8 T cells with a highly altered TCR Vß repertoire but with an unmodified phenotype
9. Natalizumab alters the TCR repertoire after one year of treatment in four MS patients
10. Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN)
11. Identification d’un score permettant le diagnostic du rejet infraclinique en transplantation rénale
12. The concept of immunothrombosis in pancreas transplantation
13. An automated histological classification system for precision diagnostics of kidney allografts
14. Peripheral blood immune cell profiling of acute corneal transplant rejection
15. Antibody-mediated allograft rejection is associated with an increase in peripheral differentiated CD28-CD8+ T cells – Analyses of a cohort of 1032 kidney transplant recipients
16. Structural insights into the catalytic mechanism of granzyme B upon substrate and inhibitor binding
17. Urinary metabolomic profiling from spontaneous tolerant kidney transplanted recipients shows enrichment in tryptophan-derived metabolites
18. Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation.
19. Time-dependent blood eosinophilia count increases the risk of kidney allograft rejection
20. Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial
21. Microbiota and immunoregulation: A focus on regulatory B lymphocytes and transplantation
22. Clinical and immunological follow-up of very long-term kidney transplant recipients treated with calcineurin inhibitors indicates dual phenotypes
23. Time-dependent lymphocyte count after transplantation is associated with higher risk of graft failure and death
24. Diagnostic performance of kSORT, a blood-based mRNA assay for noninvasive detection of rejection after kidney transplantation: A retrospective multicenter cohort study
25. Distinct peripheral blood molecular signature emerges with successful tacrolimus withdrawal in kidney transplant recipients
26. Peripheral phenotype and gene expression profiles of combined liver–kidney transplant patients
27. Unique and specific Proteobacteria diversity in urinary microbiota of tolerant kidney transplanted recipients
28. Interleukin-7 receptor blockade by an anti-CD127 monoclonal antibody in nonhuman primate kidney transplantation
29. Fine-tuning tumor- and allo-immunity: advances in the use of immune checkpoint inhibitors in kidney transplant recipients
30. Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial
31. Regulatory B Cells Expressing Granzyme B from Tolerant Renal Transplant Patients: Highly Differentiated B Cells with a Unique Pathway with a Specific Regulatory Profile and Strong Interactions with Immune System Cells.
32. Antibody Mediated Rejection and T-cell Mediated Rejection Molecular Signatures Using Next-Generation Sequencing in Kidney Transplant Biopsies.
33. New polyclonal antibodies, inhibit selectively tumor growth and invasion and synergize with immune checkpoint inhibitors
34. Increased degradation of ATP is driven by memory regulatory T cells in kidney transplantation tolerance
35. IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease
36. A composite score associated with spontaneous operational tolerance in kidney transplant recipients
37. Multiscale fluorescent tracking of immune cells in the liver with a highly biocompatible far-red emitting polymer probe
38. Fine-tuning tumor- and allo-immunity: advances in the use of immune checkpoint inhibitors in kidney transplant recipients.
39. Human granzyme B regulatory B cells prevent effector CD4+CD25- T cell proliferation through a mechanism dependent from lymphotoxin alpha
40. #4917 AN EXOME-WIDE STUDY OF RENAL OPERATIONAL TOLERANCE
41. An exome-wide study of renal operational tolerance
42. Regulation of CD8 T cell by B-cells: A narrative review
43. Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)
44. Kidney allograft rejection is associated with an imbalance of B cells, regulatory T cells and differentiated CD28-CD8+ T cells: analysis of a cohort of 1095 graft biopsies
45. Regulation of CD8 T cell by B-cells: A narrative review
46. A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft
47. Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation
48. LIS1, a glyco-humanized swine polyclonal anti-lymphocyte globulin, as a novel induction treatment in solid organ transplantation
49. Effector Memory–Expressing CD45RA (TEMRA) CD8+ T Cells from Kidney Transplant Recipients Exhibit Enhanced Purinergic P2X4 Receptor–Dependent Proinflammatory and Migratory Responses
50. Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.